PETFoundations.com Provides Instant, Easy Access to Continuing Education Courses, Reimbursement Assistance and Marketing Tools to Help Imaging Centers Thrive
DUBLIN, Ohio, April 27, 2011 — As part of its broader commitment to supporting the continued growth of molecular imaging, Cardinal Health this week introduced extensive upgrades to PETFoundations.com. This comprehensive marketing and educational Web site helps the imaging community educate physicians and other clinicians about the clinical efficacy and appropriate uses of Positron Emission Tomography (PET).
The enhanced PETFoundations.com features a new, more user-friendly design and extensive new resources, providing easy online access to:
In addition, PETFoundations.com also provides case studies and clinical protocols to help referring physicians better manage patient treatment plans and learn more about PET imaging. The site also contains relevant and up-to-date information – specific to indication and referring physician specialty – regarding approved indications and appropriate uses of PET imaging.
“We are committed to supporting the continued growth of PET imaging to aid in the diagnosis and treatment of chronic and life threatening diseases,” said John Rademacher, president of Cardinal Health’s Nuclear Pharmacy Services and Pharmacy Solutions businesses. “PETFoundations.com aims to help imaging professionals expand the use of PET products by providing easy access to the marketing, reimbursement and education tools they need to be successful.”
Cardinal Health’s Nuclear Pharmacy Services business operates the nation’s largest network of radiopharmacies, nearly 100 of which are “PET-enabled” to compound and dispense high-energy PET imaging agents in unit-dose form. The company provides a broad portfolio of high- and low- energy biomarkers to nearly 7,000 nuclear medicine facilities and imaging centers, nationwide. Its vast network of “PET-enabled” pharmacies, combined with its broad nuclear pharmacy scale, comprehensive fleet and logistics capabilities also enable the company to play a critical role in supporting clinical trials of both proprietary and non-proprietary imaging agents.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $99 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #17 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com.